Pfizer's Antiviral Pill Shows Potentially Game-Changing Results

We’re looking at two simultaneous narratives when it comes to the pandemic. The Delta variant is driving up COVID-19 hospitalizations in the mountain west, which is a worrying sign as we head into winter. On the other hand, breakthrough treatments could soon be game changers.Last Thursday, drug maker Pfizer went public with preliminary results for its experimental antiviral pill for COVID-19.”Within three days of the symptoms, you have now 89% protection from disease leading to hospitalization with our medicines, and the data indicate 100% protection from death,” Pfizer’s Dr. Mikael Dolsten said.Add to that, in the U.S., 28 million kids ages 5 to 11 became eligible this week for Pfizer’s vaccine. “By the end of the day today we estimate that over 900,000 kids ages five through 11 will have already gotten their first shot,” White House coronavirus response coordinator Jeffrey Zients said. And, on Tuesday, Pfizer asked for federal authorization to give its booster shot to any adult. Even with all these promising developments against a disease that has now killed, worldwide, more than five million people, we’re continuing to see warnings about COVID and protests against vaccine mandates and restrictions from New Zealand to Los Angeles. So what’s the truth? Are we finally turning the corner on a dark and divisive era?”I think when we stop having to worry about having access to medical care on a consistent basis, we don’t have to worry about our hospitals getting overrun,” UC Health’s Dr. Michelle Barron said. “I think that’s going to be the key for a lot of us, at least in the medical community, how we’re viewing it because that’s and death rates, obviously as well.”The pill is not approved yet, but it’s set to change our reality. In trials of those who got the pill fewer than 1% needed to be hospitalized and no one died. None of these people were vaccinated. The study was halted based on the strength of the results.Approval of the new drug could take months. Merck, which announced preliminary results last month showing its drug cut hospitalizations and deaths by half, is awaiting FDA emergency use authorization for older, and other high-risk adults. It’s already approved in the UK.And here’s the big ‘But’: Both the Pfizer and Merck pills, to be effective, need to be taken during an early, narrow window after symptoms appear about three days. Some people, at this phase, might not realize they’ve got COVID-19.”I think that is a huge phenomenon that is …

Read more

Show More

Related Articles

Back to top button